Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4874658
Max Phase: Preclinical
Molecular Formula: C36H45N7O5
Molecular Weight: 655.80
Molecule Type: Unknown
Associated Items:
ID: ALA4874658
Max Phase: Preclinical
Molecular Formula: C36H45N7O5
Molecular Weight: 655.80
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O
Standard InChI: InChI=1S/C36H45N7O5/c37-17-5-4-9-30(34(39)46)42-35(47)31(19-23-11-13-25(14-12-23)24-7-2-1-3-8-24)43-36(48)32(41-33(45)10-6-18-38)20-26-22-40-29-16-15-27(44)21-28(26)29/h1-3,7-8,11-16,21-22,30-32,40,44H,4-6,9-10,17-20,37-38H2,(H2,39,46)(H,41,45)(H,42,47)(H,43,48)/t30-,31-,32-/m0/s1
Standard InChI Key: UAQQDAYCKBFCNC-CPCREDONSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 655.80 | Molecular Weight (Monoisotopic): 655.3482 | AlogP: 2.13 | #Rotatable Bonds: 18 |
Polar Surface Area: 218.45 | Molecular Species: BASE | HBA: 7 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.47 | CX Basic pKa: 10.29 | CX LogP: 0.56 | CX LogD: -3.31 |
Aromatic Rings: 4 | Heavy Atoms: 48 | QED Weighted: 0.07 | Np Likeness Score: 0.10 |
1. Baggio C, Kulinich A, Dennys CN, Rodrigo R, Meyer K, Ethell I, Pellecchia M.. (2021) NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands., 64 (15.0): [PMID:34293864] [10.1021/acs.jmedchem.1c00608] |
Source(1):